Objective: To observe the clinical efficacy of a Jing ethnic prescription in treating chronic atrophic gastritis (CAG). Methods: A total of 182 CAG patients admitted to our hospital were randomly divided into a control group (91 cases) and a treatment group (91 cases) based on their admission order. The control group received conventional treatment, while the treatment group was treated with a Jing ethnic prescription. The clinical efficacy, changes in gastric mucosa-related indicators, and systemic inflammatory markers were compared between the two groups. Results: After treatment, the overall effective rate in the treatment group was higher than that in the control group, but the difference was not statistically significant (P > 0.05). The levels of trefoil factor 2 (TFF2) in the gastric mucosa increased, and the levels of nuclear factor-kappa B (NF-κB) decreased in both groups. However, the improvement in these indicators was significantly better in the treatment group (P < 0.05). The serum levels of interleukin-6 (IL-6), interleukin-8 (IL-8), and high-sensitivity C-reactive protein (hs-CRP) were lower after treatment in both groups, and the levels in the treatment group were significantly lower than those in the control group (P < 0.05). Conclusion: The custom formula of the Jing ethnic group shows comparable clinical efficacy to conventional treatment for chronic atrophic gastritis (CAG), but it demonstrates significantly better effects in reducing systemic inflammatory responses. Specifically, the treatment group showed superior results in the following aspects compared to the control group: increased levels of TFF2, decreased levels of NF-κB, and reduced serum levels of IL-6, IL-8, and hs-CRP.
References
[1]
Shi, Y.Q., Chen, M., Wang, X.H., et al. (2022) Expert Consensus on the Diagnosis and Treatment of Chronic Atrophic Gastritis and the Clinical Application of Lamb Stomach Extract with Vitamin B12. Chinese Journal of Gastroenterology, 27, 657-664.
[2]
Yan, H.M., Dai, L., Xu, D., et al. (2023) Efficacy of Integrated Traditional Chinese and Western Medicine in Treating Chronic Superficial Gastritis with Coldness and Deficiency of the Spleen and Stomach and Its Effects on Peripheral Blood Gastrointestinal Hormones, T-Lymphocyte Subsets, IL-8, IL-32, and MCP-1. Chinese Archives of Traditional Chinese Medicine, 41, 156-159.
[3]
Du, Y.L., Liu, X.Y. and Tian, S. (2024) Observation on the Efficacy of Modified Liver-Soothing and Spleen-Strengthening Formula Combined with Moluo Pill in Treating Chronic Atrophic Gastritis with Liver Qi Stagnation and Spleen Deficiency Syndrome. Hubei Journal of Traditional Chinese Medicine, 46, 6-9.
[4]
Li, J.X., Chen, Z., Lyu, B., et al. (2018) Consensus Opinion on the Diagnosis and Treatment of Chronic Atrophic Gastritis with Integrated Traditional Chinese and Western Medicine (2017). Chinese Journal of Integrated Traditional and Western Medicine on Digestion, 26, 121-131.
[5]
Xiao, Q., Hao, E.W., Du, Z.C., et al. (2022) Analysis of Clinical Prescription Usage Patterns Containing Buddha’s Hand Based on Data Mining. Chinese Journal of Experimental Traditional Medical Formulae, 28, 194-203.
[6]
She, R.R., Guo, J.W. and Ge, H.N. (2023) Effects of Qi-Tonifying, Blood-Activating, and Collaterals-Unblocking Formula on PTEN in Gastric Mucosa and Serum IL-6 and TNF-α in Patients with Chronic Atrophic Gastritis of Qi Deficiency and Blood Stasis Type. Journal of Zhejiang Chinese Medical University, 47, 52-57.
[7]
Fan, X.Y., Shi, C.H., Xu, Y.M., et al. (2022) Effects of Helicobacter pylori Infection on the HGF/c-Met Signaling Pathway in Gastric Tissue of Patients with Chronic Atrophic Gastritis. Chinese Journal of Nosocomiology, 32, 2799-2802.
